INSERT THERAPEUTICS
Insert Therapeutics’ proprietary technologies provide for the intracellular delivery of a broad range of therapeutics. Insert Therapeutics has developed a new class of polymers that are designed and synthesized specifically for use as non-immunogenic, systemic delivery vehicles capable of accommodating therapeutics of any size, ranging from small molecules to plasmid DNA, as well as their combinations.
Similar Organizations
Coelacanth
Coelacanth, which uses proprietary chemistry technologies to rapidly discover new chemical entities for drug development.
Rani Therapeutics
Rani Therapeutics develops bio-therapeutics technology for the oral delivery of large drug molecules.
SanoGene Therapeutics
SanoGene Therapeutics is a biotechnology company that develops biopharmaceutical.